ArticleCancers2021

Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy.

Jimmy Stalin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.